FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
+13.7%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$129M
AUM Growth
+$129M
(-1%)
Cap. Flow
-$45.6M
Cap. Flow
% of AUM
-35.39%
Top 10 Holdings %
Top 10 Hldgs %
99.7%
Holding
14
New
–
Increased
3
Reduced
2
Closed
3
Top Buys
| 1 |
Hims & Hers Health
HIMS
|
$4.63M |
| 2 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$1.25M |
| 3 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
$1.08M |
Top Sells
| 1 |
Disc Medicine
IRON
|
$43.6M |
| 2 |
Invivyd
IVVD
|
$4.48M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$2.19M |
| 4 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
$1.16M |
| 5 |
Adicet Bio
ACET
|
$1.08M |
Sector Composition
| 1 | Healthcare | 79.88% |
| 2 | Consumer Staples | 20.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Hims & Hers Health
HIMS
$9.57B
| $25.9M | 20.12% | 4,041,383 +721,597 | +22% | +$4.63M |
|
2
Compass Therapeutics
CMPX
$483M
| $22.1M | 17.19% | 4,400,000 | – | – |
|
3
Aclaris Therapeutics
ACRS
$209M
| $19.8M | 15.39% | 1,258,243 | – | – |
|
|
THRX
4
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $17.9M | 13.87% | 3,585,346 +250,000 | +7% | +$1.25M |
|
|
PRDS
5
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $17M | 13.18% | 10,037,935 +637,420 | +7% | +$1.08M |
|
|
SLGC
6
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $8.83M | 6.86% | 3,516,472 | – | – |
|
|
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $5.34M | 4.15% | 875,001 | – | – |
|
|
8
Adicet Bio
ACET
$59.9M
| $4.99M | 3.88% | 558,636 -121,364 | -18% | -$1.08M |
|
|
9
Disc Medicine
IRON
$2.07B
| $4.84M | 3.76% | 243,513 -2,191,612 | -90% | -$43.6M |
|
10
Quantum-Si Incorporated
QSI
$227M
| $1.69M | 1.31% | 924,379 | – | – |
|
11
Pharvaris
PHVS
$1.39B
| $384K | 0.3% | 34,142 | – | – |
|
|
12
Invivyd
IVVD
$204M
| – | – | -1,431,826 | Closed | -$4.48M |
|
|
ME
13
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| – | – | -406,913 | Closed | -$1.16M |
|
|
14
Enanta Pharmaceuticals
ENTA
$180M
| – | – | -42,250 | Closed | -$2.19M |
|